N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs)
N-hydroxyurea is an organic chemical compound – N-hydroxydiamide of carbonic acid. At room temperature, it is a solid and white crystalline powder (needle), odorless, water-soluble. N-hydroxyurea is an antineoplastic drug registered for the treatment of patients with chronic myelogenous leukemia and...
Main Author: | |
---|---|
Format: | Article in Journal/Newspaper |
Language: | Polish |
Published: |
Centralny Instytut Ochrony Pracy
2017
|
Subjects: | |
Online Access: | https://doi.org/10.5604/01.3001.0010.594 https://bibliotekanauki.pl/articles/137943.pdf https://bibliotekanauki.pl/articles/137943 |
id |
fttriple:oai:gotriple.eu:oai:bibliotekanauki.pl:137943 |
---|---|
record_format |
openpolar |
spelling |
fttriple:oai:gotriple.eu:oai:bibliotekanauki.pl:137943 2023-05-15T15:53:00+02:00 N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs) N-Hydroksymocznik – frakcja wdychana : dokumentacja proponowanych dopuszczalnych wielkości narażenia zawodowego Kupczewska-Dobecka, M. 2017-01-01 https://doi.org/10.5604/01.3001.0010.594 https://bibliotekanauki.pl/articles/137943.pdf https://bibliotekanauki.pl/articles/137943 pl pol Centralny Instytut Ochrony Pracy doi:10.5604/01.3001.0010.594 https://bibliotekanauki.pl/articles/137943.pdf https://bibliotekanauki.pl/articles/137943 other Podstawy i Metody Oceny Środowiska Pracy; 2017, 4 (94); 55-87 1231-868X geo Journal Article https://vocabularies.coar-repositories.org/resource_types/c_6501/ 2017 fttriple https://doi.org/10.5604/01.3001.0010.594 2023-01-22T19:09:42Z N-hydroxyurea is an organic chemical compound – N-hydroxydiamide of carbonic acid. At room temperature, it is a solid and white crystalline powder (needle), odorless, water-soluble. N-hydroxyurea is an antineoplastic drug registered for the treatment of patients with chronic myelogenous leukemia and sickle cell anemia, and idiopathic thrombocytopenia and polycythemia. Occupational exposure to N-hydroxyurea occurs during manufacturing, packing, using on a daily basis in hospitals and in veterinary practice. There is no data on the number of people exposed to N-hydroxyurea in Poland. N-hydroxyurea is completely absorbed from the gastrointestinal tract. After oral administration, the maximum plasma concentration is within 1 ÷ 4 h after ingestion. LD50 value after intragastric administration to rats is 5760 mg/kg and mice 7330 mg/kg. N-hydroxyurea does not meet the classification criteria established in the European Union for acute toxicity after oral administration established. IARC classifies N-hydroxycarbamide into group 3, i.e., substances that cannot be classified for human carcinogenicity. Main effects of N-hydroxyurea in humans include systemic toxicity manifested by suppression of bone marrow at therapeutic doses (the lowest therapeutic dose is 15 mg/kg). The side effect of hydroxycarbamide is bone marrow suppression resulting in neutropenia, granulocytopenia, thrombocytopenia, leukopenia and increased bone marrow mass. In laboratory animals treated with N- hydroxyurea at doses higher than clinical doses established for humans, cardiovascular disorders (e.g., heart rate changes, blood pressure and ECG changes), haemolysis and methemoglobinemia were observed. In subchronic and chronic studies in rats, a dosedependent, weak or moderate bone marrow hypoplasia and pulmonary congestion were observed. Dose of 50 mg/kg is the NOAEL value for the effect of N-hydroxyurea on blood parameters in rats treated with aqueous solution for 10 days. The hydroxyurea-induced genotoxic effects in humans have been observed in ... Article in Journal/Newspaper Carbonic acid Unknown Sickle ENVELOPE(-66.783,-66.783,-68.867,-68.867) |
institution |
Open Polar |
collection |
Unknown |
op_collection_id |
fttriple |
language |
Polish |
topic |
geo |
spellingShingle |
geo Kupczewska-Dobecka, M. N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs) |
topic_facet |
geo |
description |
N-hydroxyurea is an organic chemical compound – N-hydroxydiamide of carbonic acid. At room temperature, it is a solid and white crystalline powder (needle), odorless, water-soluble. N-hydroxyurea is an antineoplastic drug registered for the treatment of patients with chronic myelogenous leukemia and sickle cell anemia, and idiopathic thrombocytopenia and polycythemia. Occupational exposure to N-hydroxyurea occurs during manufacturing, packing, using on a daily basis in hospitals and in veterinary practice. There is no data on the number of people exposed to N-hydroxyurea in Poland. N-hydroxyurea is completely absorbed from the gastrointestinal tract. After oral administration, the maximum plasma concentration is within 1 ÷ 4 h after ingestion. LD50 value after intragastric administration to rats is 5760 mg/kg and mice 7330 mg/kg. N-hydroxyurea does not meet the classification criteria established in the European Union for acute toxicity after oral administration established. IARC classifies N-hydroxycarbamide into group 3, i.e., substances that cannot be classified for human carcinogenicity. Main effects of N-hydroxyurea in humans include systemic toxicity manifested by suppression of bone marrow at therapeutic doses (the lowest therapeutic dose is 15 mg/kg). The side effect of hydroxycarbamide is bone marrow suppression resulting in neutropenia, granulocytopenia, thrombocytopenia, leukopenia and increased bone marrow mass. In laboratory animals treated with N- hydroxyurea at doses higher than clinical doses established for humans, cardiovascular disorders (e.g., heart rate changes, blood pressure and ECG changes), haemolysis and methemoglobinemia were observed. In subchronic and chronic studies in rats, a dosedependent, weak or moderate bone marrow hypoplasia and pulmonary congestion were observed. Dose of 50 mg/kg is the NOAEL value for the effect of N-hydroxyurea on blood parameters in rats treated with aqueous solution for 10 days. The hydroxyurea-induced genotoxic effects in humans have been observed in ... |
format |
Article in Journal/Newspaper |
author |
Kupczewska-Dobecka, M. |
author_facet |
Kupczewska-Dobecka, M. |
author_sort |
Kupczewska-Dobecka, M. |
title |
N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs) |
title_short |
N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs) |
title_full |
N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs) |
title_fullStr |
N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs) |
title_full_unstemmed |
N-Hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (OELs) |
title_sort |
n-hydroxyurea – inhalable fraction : documentation of proposed values of occupational exposure limits (oels) |
publisher |
Centralny Instytut Ochrony Pracy |
publishDate |
2017 |
url |
https://doi.org/10.5604/01.3001.0010.594 https://bibliotekanauki.pl/articles/137943.pdf https://bibliotekanauki.pl/articles/137943 |
long_lat |
ENVELOPE(-66.783,-66.783,-68.867,-68.867) |
geographic |
Sickle |
geographic_facet |
Sickle |
genre |
Carbonic acid |
genre_facet |
Carbonic acid |
op_source |
Podstawy i Metody Oceny Środowiska Pracy; 2017, 4 (94); 55-87 1231-868X |
op_relation |
doi:10.5604/01.3001.0010.594 https://bibliotekanauki.pl/articles/137943.pdf https://bibliotekanauki.pl/articles/137943 |
op_rights |
other |
op_doi |
https://doi.org/10.5604/01.3001.0010.594 |
_version_ |
1766388070647595008 |